MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1155/2013/518968

Медицинская библиотека · ISRN cardiology · 2013

Dual antiplatelet therapy can be discontinued at three months after implantation of zotarolimus-eluting stent in patients with coronary artery disease.

Wada Tadashi, Nakahama Makoto, Toda Hironobu, Watanabe Atsuyuki, Hashimoto Katsushi, Terasaka Ritsuko, Nakamura Kazufumi, Yamada Nobuyuki, Ito Hiroshi

СтатьяПеревод пока не подготовлен

Аннотация

Dual antiplatelet therapy (DAPT) after percutaneous coronary intervention increases the risk of bleeding. We studied the safety and clinical outcomes of switching from DAPT to aspirin monotherapy at 3 months after ZES implantation. We retrospectively evaluated 168 consecutive patients with coronary artery disease who had been implanted with a ZES from June 2009 through March 2010. After excluding 40 patients according to exclusion criteria such as myocardial infarction, 128 patients were divided into a 3-month DAPT group (67 patients, 88 lesions) and a 12-month conventional DAPT group (61 patients, 81 lesions). Coronary angiographic followup and clinical followup were conducted at more than 8 months and at 12 months after ZES implantation, respectively. Minor and major bleeding events, stent thrombosis (ST), and major adverse cardiac events (MACE) (death, myocardial infarction, cerebrovascular accident, target lesion revascularization, and target vessel revascularization) were evaluated. There were no statistically significant differences in the incidences of ST and MACE between the two groups. The incidence of bleeding events was significantly lower in the 3-month group than in the 12-month group (1.5% versus 11.5%, P < 0.05). DAPT can be safely discontinued at 3 months after ZES implantation, which reduces bleeding risk.

Для цитирования: Wada Tadashi, Nakahama Makoto, Toda Hironobu, Watanabe Atsuyuki, Hashimoto Katsushi, Terasaka Ritsuko, Nakamura Kazufumi, Yamada Nobuyuki, Ito Hiroshi. Dual antiplatelet therapy can be discontinued at three months after implantation of zotarolimus-eluting stent in patients with coronary artery disease.. ISRN cardiology. 2013. DOI: 10.1155/2013/518968.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.